English | Español

Biospace
Patient Daily | Mar 4, 2026

Appellate court rules for REGENXBIO over Sarepta in gene therapy patent case
Patient Daily | Mar 4, 2026

Gene therapies for sickle cell disease face slow uptake despite early promise
Patient Daily | Mar 4, 2026

Gilead announces plan to acquire Arcellx for $7.8 billion ahead of FDA decision
Patient Daily | Mar 4, 2026

Merck may retain Keytruda exclusivity longer than expected amid looming biosimilar competition
Patient Daily | Mar 4, 2026

Radiopharmaceutical makers adjust supply chains amid fast-decaying products
Patient Daily | Mar 4, 2026

Corsera Health develops annual preventive therapy for cardiovascular disease
Patient Daily | Mar 4, 2026

Roche seeks partner for Rocephin production amid rising costs in Switzerland
Patient Daily | Mar 4, 2026

Novo Nordisk partners with Vivtex for $2.1B oral weight loss drug development

Trending
Patient Daily | Mar 6, 2026

Dallas Breathe Free ranked top ENT practice in region by reviewers on Google
+ Regulatory
Patient Daily | Mar 5, 2026

TPA Director: RFK Jr.'s 'latest ideological crusade would be great for trial lawyers, but terrible for millions of patients'
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'